Kotlin 2.3.20 ships name-based destructuring, default Build Tools API on Kotlin/JVM, Gradle 9.3.0 compatibility, and Wasm string performance gains of up to 4.6 times.
A missing authentication check on a Model Context Protocol endpoint in nginx-ui exposes roughly 2,600 servers to full takeover, and unauthenticated exploitation is practical when paired with a second flaw that leaks a required node secret.
Mozilla released Firefox 150 on April 21, 2026, fixing 271 vulnerabilities surfaced by Anthropic's Claude Mythos Preview in a security sweep Mozilla's CTO calls a turning point for defender-side AI.
Capcom says its sci-fi shooter Pragmata sold over one million units in two days after launch, turning a twice-delayed six-year project into its most successful original IP debut in years.
Moonshot released Kimi K2.6 under a modified MIT license, claiming parity with GPT-5.4 and Claude Opus 4.6 on coding benchmarks while orchestrating agent swarms that run for half a day unattended.
Meta signed a reservation deal for up to 100 GWh of ultra-long-duration storage from Noon Energy, a startup whose reversible fuel cell borrows chemistry from NASA's MOXIE Mars experiment.
Apple's first AirPods Max refresh since 2020 swaps in the H2 chip and inherits AirPods Pro 3 features while keeping the unchanged industrial design, weight, and rated 20-hour battery life.
For the first time in 25 years, the FBI's IC3 annual report carves out a standalone artificial intelligence section, formally recognizing AI-enabled fraud as a distinct policy concern.
QUT and Baker-lab researchers built AI-designed allosteric switches that turn on in the presence of small molecules, peptides, or whole proteins and work inside bacteria or on electrodes.
pnpm 11's release candidate ships minimumReleaseAge=1 day, blockExoticSubdeps, and strictDepBuilds as defaults, baking lessons from the March 2026 Trivy and axios attacks into the package manager itself.
At its April 21 Super Technology Day in Beijing, CATL introduced a new ultra-fast charging LFP cell that outpaces BYD's recently unveiled Blade Battery 2.0 and reshapes the fast-charging race.
Denali's tividenofusp alfa becomes the first FDA-approved biologic engineered to cross the blood-brain barrier, breaking a long rare-disease rejection streak and validating a transport-vehicle platform that could unlock CNS access for many more drugs.